SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-15-000003
Filing Date
2015-08-13
Accepted
2015-08-13 08:00:53
Documents
3
Period of Report
2015-08-13
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K ebio-063015x8k.htm 8-K 34527
2 EXHIBIT 99 q22015earningsprv3.htm EX-99 115794
3 ebiologo.jpg GRAPHIC 15878
  Complete submission text file 0001485003-15-000003.txt   173384
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 151048747
SIC: 2834 Pharmaceutical Preparations